Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

MBI RESPIRATORY AND SKIN DISEASES EXAM 4 REVIEW 100% VERIFIED!!, Exams of Advanced Education

MBI RESPIRATORY AND SKIN DISEASES EXAM 4 REVIEW 100% VERIFIED!!

Typology: Exams

2024/2025

Available from 05/15/2025

Smartsolutions
Smartsolutions 🇺🇸

2.3

(3)

11K documents

1 / 12

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
MBI RESPIRATORY AND SKIN DISEASES EXAM 4 REVIEW
100% VERIFIED!!
COVID-19 - ANSWER Agent: severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2); Signs: asymptomatic, mild (flu-like & loss of taste/smell), or severe
(difficulty breathing, confusion, headaches, sleep problems); Complications: secondary
bacterial pneumonia, overactive immune responses, & many others; Treatment:
antivirals (early); supportive care; Prevention: vaccination & isolation of cases.
Respiratory Tract Host Defenses - ANSWER URT: pharynx/throat, nose, sinuses, ears;
URT defenses: mucous membranes, sneezing, coughing, & normal microbiota; LRT:
trachea, bronchi, bronchioles, & lungs; LRT defenses: epiglottis, mucous membranes,
ciliary escalator, coughing, & sneezing.
Chain of Transmission - ANSWER Primary mode of transmission: droplets; General
prevention strategies: handwashing, cover nose/mouth, & disinfection of surfaces.
RSV Disease - ANSWER Agent: respiratory syncytial virus (RSV); Most individuals: mild
cold-like illness; Infants & elderly: early flu-like then bronchitis & pneumonia causes
distinctive wheezing; Treatment: antivirals for severe; supportive care; Prevention:
vaccination & antibodies (passive immunity) for high-risk infants.
Common cold - ANSWER Agents (200+): rhinoviruses & coronaviruses; Signs: rhinitis &
coughing; Complications: secondary bacterial infections - sinusitis & otitis media;
Treat/Prevent: no antivirals, general prevention.
Pertussis - ANSWER Agent: Bordetella pertussis bacteria; Exotoxins: pertussis toxin
(thick ropey mucus); Sign: severe coughing; High risk: infants, young children;
Complication: secondary bacterial pneumonia; Treatment: EARLY antibiotics;
Prevention: vaccination, isolation and antibiotics for cases, & prophylaxis for close
contacts.
Streptococcal Pharyngitis - ANSWER Agent: Streptococcus pyogenes bacteria; Signs of
pf3
pf4
pf5
pf8
pf9
pfa

Partial preview of the text

Download MBI RESPIRATORY AND SKIN DISEASES EXAM 4 REVIEW 100% VERIFIED!! and more Exams Advanced Education in PDF only on Docsity!

MBI RESPIRATORY A 1 N00%D S KVEIN DRIFIEISEAD!!SES EXAM 4 REVIEW

COVID-19 - ANSWER Agent: severe acute respiratory syndrome coronavirus-2(SARS-CoV-2); Signs: asymptomatic, mild (flu-like & loss of taste/smell), or severe (difficulty breathing, confusion, headaches, sleep problems); Complications: secondarybacterial pneumonia, overactive immune responses, & many others; Treatment: antivirals (early); supportive care; Prevention: vaccination & isolation of cases. Respiratory Tract Host Defenses - ANSWER URT: pharynx/throat, nose, sinuses, ears;URT defenses: mucous membranes, sneezing, coughing, & normal microbiota; LRT: trachea, bronchi, bronchioles, & lungs; LRT defenses: epiglottis, mucous membranes,ciliary escalator, coughing, & sneezing.

Chain of Transmission - ANSWER Primary mode of transmission: droplets; Generalprevention strategies: handwashing, cover nose/mouth, & disinfection of surfaces.

RSV Disease - ANSWER Agent: respiratory syncytial virus (RSV); Most individuals: mildcold-like illness; Infants & elderly: early flu-like then bronchitis & pneumonia causes distinctive wheezing; Treatment: antivirals for severe; supportive care; Prevention:vaccination & antibodies (passive immunity) for high-risk infants.

Common cold - ANSWER Agents (200+): rhinoviruses & coronaviruses; Signs: rhinitis &coughing; Complications: secondary bacterial infections - sinusitis & otitis media; Treat/Prevent: no antivirals, general prevention. Pertussis - ANSWER Agent: Bordetella pertussis bacteria; Exotoxins: pertussis toxin(thick ropey mucus); Sign: severe coughing; High risk: infants, young children; Complication: secondary bacterial pneumonia; Treatment: EARLY antibiotics;Prevention: vaccination, isolation and antibiotics for cases, & prophylaxis for close contacts. Streptococcal Pharyngitis - ANSWER Agent: Streptococcus pyogenes bacteria; Signs of

pharyngitis: pharyngitis and fever; Diagnostic tests for streptococcal pharyngitis:Agglutination test (rapid; antibody-antigen), Blood agar test (overnight; hemolysin test).

Scarlet Fever - ANSWER Agent: Streptococcus pyogenes; Signs of scarlet fever:pharyngitis, fever, bright red sandpaper-like rash (erythrogenic toxin); Complication: rheumatic fever an autoimmune disease of heart valves and/or joints (arthritis);Treatment: EARLY antibiotics; Prevention: vaccination, isolation and antibiotics for cases, & prophylaxis for close contacts. Pneumococcal pneumonia - ANSWER Agent: Streptococcus pneumoniae bacteria;Infection of the lungs: signs are fever, cough, chest pain, shortness of breath, discolored sputum; Complications: otitis media, sinusitis, septicemia, & meningitis;Treatment: antibiotics, resistance is serious threat; Prevention: vaccination & isolation.

Influenza - ANSWER Agent: influenza viruses; Antigenic drift - spontaneous mutations inantigen genes of individual viruses → yearly epidemics; Antigenic shift: mixing of antigen genes from pig/bird/humanheadache, & cough; Complication: secondary bacterial pneumonia; Treatment: antiviral → new viruses; pandemics; Signs: fever, fatigue, aches, (early), resistance problem; Prevention: vaccination & isolation of cases. Tuberculosis (TB) - ANSWER Agent: Mycobacterium tuberculosis bacteria; Latent TB:low bacteria # in lungs, (+) skin test for immune response, NO signs, NOT transmissible; Active TB: high bacteria # in lungs, (+) skin test, (+) sputum test detects bacteria, (+)chest x-ray = lung damage, pneumonia signs, transmissible; Treatment: antibiotic, serious resistance threat use drug combinations & directly observed therapy; Prevent inU.S.: skin test; treat latent & active TB.

Skin Structure & Defenses - ANSWER Epidermis (outer layer): inhibits/kills microbeswith salt, acid, lysozyme, dryness (keratin), sheds to remove microbes, normal microbiota, tightly packed cells prevent entry into dermis; Dermis (lower layer): onlysecond line nonspecific host defenses & immune responses.

Folliculitis - ANSWER Agent: Staphylococcus aureus bacteria; Transmits by contact;infects hair follicles; Signs (inflammation): red, swelling, pain, pus; High risk: chronic carriers; Treat: incision/drainage to reduce selective pressure for antibiotic resistance;antibiotics only if needed; Prevention: hygiene, handwashing, barriers (bandages, gloves, etc.), & disinfect surfaces.

erythrogenic toxin. Signs: pharyngitis, fever, bright red sandpaper-like rash(erythrogenic toxin). Complication: rheumatic fever.

Pneumococcal pneumonia - ANSWER Agent: Streptococcus pneumoniae bacteria.Infection of the lungs: signs are fever, cough, chest pain, shortness of breath, discolored sputum. Complications: otitis media, sinusitis, septicemia, & meningitis. Influenza - ANSWER Agent: influenza viruses. Antigenic drift - spontaneous mutations inantigen genes of individual viruses → yearly epidemics; new vaccine needed yearly. Antigenic shift: mixing of antigen genes from pig/bird/human → new viruses; pandemics. Tuberculosis (TB) - ANSWER Agent: Mycobacterium tuberculosis bacteria. Latent TB:low bacteria # in lungs, (+) skin test for immune response, NO signs, NOT transmissible. Active TB: high bacteria # in lungs, (+) skin test, (+) sputum test detects bacteria, (+)chest x-ray = lung damage, pneumonia signs, transmissible.

Skin Structure & Defenses - ANSWER Epidermis (outer layer): inhibits/kills microbeswith salt, acid, lysozyme, dryness (keratin), sheds to remove microbes, normal microbiota, tightly packed cells prevent entry into dermis. Dermis (lower layer): onlysecond line nonspecific host defenses & immune responses.

Folliculitis - ANSWER Agent: Staphylococcus aureus bacteria. Transmits by contact;infects hair follicles. Signs (inflammation): red, swelling, pain, pus. High risk: chronic carriers. Measles - ANSWER Agent: measles virus. Mode of transmission: droplets. Infection ofrespiratory tract → blood → skin. Disables cell-mediated immune responses. Signs: maculopapular rash, high fever. Impetigo - ANSWER Agents: S. aureus and/or S. pyogenes. Signs: red sores on the face,especially around the nose and mouth.

Treatment for COVID-19 - ANSWER Antivirals (early); supportive care.

Prevention for COVID-19 - ANSWER Vaccination & isolation of cases. Chain of Transmission for COVID-19 - ANSWER Primary mode of transmission: droplets. General Prevention Strategies - ANSWER Handwashing, cover nose/mouth, &disinfection of surfaces.

Treatment for RSV Disease - ANSWER Antivirals for severe; supportive care. Prevention for RSV Disease - ANSWER Vaccination & antibodies (passive immunity) forhigh-risk infants.

Treatment for Pertussis - ANSWER EARLY antibiotics. Prevention for Pertussis - ANSWER Vaccination, isolation and antibiotics for cases, &prophylaxis for close contacts.

Treatment for Pneumococcal pneumonia - ANSWER Antibiotics early reduces rheumaticfever.

Prevention for Pneumococcal pneumonia - ANSWER Antibiotics & isolation of cases. Treatment for Influenza - ANSWER Antiviral (early), resistance problem. Prevention for Influenza - ANSWER Vaccination & isolation of cases. Treatment for Tuberculosis - ANSWER Antibiotic, serious resistance threat use drugcombinations & directly observed therapy.

Rubella agent - ANSWER Rubella virus. Modes of transmission for rubella - ANSWER Droplets & vertical. Rubella infection process - ANSWER Infects respiratory tract → blood → skin. Symptoms of rubella - ANSWER Asymptomatic or mild rash/fever. Congenital rubella syndrome (CNS) effects - ANSWER Causing miscarriage, stillbirth,premature birth, deafness, blindness, & developmental disabilities.

Gas gangrene agent - ANSWER Clostridium perfringens bacteria in soil. Gas gangrene infection process - ANSWER C. perfringens endospores in soil contact oxygen-free dermis → germinate → multiply. →

Gas gangrene complications - ANSWER Causes tissue death & rapid spread. High risk for gas gangrene - ANSWER Deep wounds, diabetes. Treatment for gas gangrene - ANSWER Surgically remove dead tissue, antibiotics. Prevention of gas gangrene - ANSWER Wound care, prophylaxis. Chickenpox agent - ANSWER Varicella zoster virus (VZV). Transmission of chickenpox - ANSWER Droplets (lungs/skin) & vertical.

Chickenpox infection process - ANSWER Infects respiratory tract → blood → skin. Nervous System Diseases components - ANSWER CNS (brain, spinal cord) andperipheral nerves.

Physical defenses of CNS - ANSWER Bones, meninges, cerebral spinal fluid, blood-brainbarrier (low permeability blood vessels in the brain).

Signs of CNS infections - ANSWER Itchy skin vesicles & fever. High risk for CNS infections - ANSWER Infants, pregnant women, adults. Complications of CNS infections - ANSWER Secondary bacterial skin infections,secondary bacterial pneumonia; viral encephalitis; congenital disease.

Meningitis agents - ANSWER Bacteria, viruses, and fungi. Signs of meningitis - ANSWER Painful stiff neck, severe headache, fever, photophobia, &white blood cells in CSF.

Bacterial meningitis risk - ANSWER Most life threatening. Shingles agent - ANSWER VZV reactivates after chickenpox. Signs of shingles - ANSWER Painful skin vesicles; peripheral nerve pain. Shingles complications - ANSWER Chronic peripheral nerve pain.

Lyme Disease complications - ANSWER Post-treatment syndrome. Lyme Disease treatment - ANSWER Antibiotics. Lyme Disease prevention - ANSWER Avoid/prevent tick bites. Meningococcal meningitis - ANSWER Agent: Neisseria meningitidis bacteria; Most likelycause of meningitis outbreaks.

Meningococcal meningitis high risk - ANSWER Infants & young adults. Sexually Transmitted Diseases (STDs) - ANSWER Often asymptomatic; STDs inflammation → increase HIV infection; Transmission: direct sexual contact. →

STD unique sign/treatment - ANSWER Petechiae (black rash) due to endotoxin surgically remove tissue. →

Listeriosis & Listeria meningitis - ANSWER Agent: Listeria monocytogenes,opportunistic; Foodborne: soil contaminated meats, unpasteurized dairy, & produce.

Listeriosis complications - ANSWER Most cases: asymptomatic/mild gastroenteritis;Elderly: meningitis and/or septicemia; Vertical transmission: miscarriage/fetal death.

Listeriosis treatment - ANSWER Antibiotics early! Listeriosis prevention - ANSWER Avoid high risk foods, cook meats, wash fruits andveggies, NO vaccine.

Bacterial STDs - ANSWER Chlamydia & gonorrhea; No effective immune response toclear pathogen; No immunity to future disease.

Chlamydia - ANSWER Agent: Chlamydia trachomatis bacteria; Most asymptomatic ="silent STD"; Complications: neonatal eye infections.

West Nile Virus (WNV) Disease - ANSWER Agent: West Nile virus (WNV); Reservoir:birds (zoonosis); Transmission: vector (mosquito).

West Nile Virus signs - ANSWER Asymptomatic, mild flu-like, or pneumonia; females PIDencephalitis (high fever, headache, painful stiff neck, flaccid paralysis, coma & death).

West Nile Virus high risk - ANSWER Elderly. West Nile Virus treatment - ANSWER No antivirals, supportive care only! West Nile Virus prevention - ANSWER Disrupt mosquito transmission. Gonorrhea - ANSWER Agent: Neisseria gonorrhoeae bacteria; Signs/symptoms: pain &discharge; Complications: severe neonatal eye infections; males inflammation spreads; females PID. Gonorrhea antibiotic resistance - ANSWER Urgent threat! Pelvic inflammatory disease (PID) - ANSWER Untreated chlamydia or gonorrheaspreads to uterus, fallopian tubes, & ovaries; complications include chronic pain, secondary infections, ectopic pregnancy, & infertility. Cryptosporidiosis - ANSWER Agent: Cryptosporidium species protozoa, cyst inenvironment; transmission is fecal-oral, primarily by water; signs include diarrhea, chronic if immune compromised.